MetLife Investment Management’s Geron GERN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $373K | Sell |
250,662
-46,400
| -16% | -$70.5K | ﹤0.01% | 1895 |
|
|
2025
Q4 | $392K | Buy |
297,062
+30,313
| +11% | +$38K | ﹤0.01% | 1910 |
|
|
2025
Q3 | $365K | Sell |
266,749
-96,388
| -27% | -$128K | ﹤0.01% | 1963 |
|
|
2025
Q2 | $512K | Buy |
363,137
+57,829
| +19% | +$82K | ﹤0.01% | 1668 |
|
|
2025
Q1 | $485K | Sell |
305,308
-42,611
| -12% | -$104K | ﹤0.01% | 1745 |
|
|
2024
Q4 | $1.23M | Buy |
347,919
+24,260
| +7% | +$96.9K | 0.01% | 1309 |
|
|
2024
Q3 | $1.47M | Sell |
323,659
-9,103
| -3% | -$41.4K | 0.01% | 1180 |
|
|
2024
Q2 | $1.41M | Buy |
332,762
+61,188
| +23% | +$239K | 0.01% | 1153 |
|
|
2024
Q1 | $896K | Buy |
271,574
+8,912
| +3% | +$20K | 0.01% | 1355 |
|
|
2023
Q4 | $554K | Hold |
262,662
| – | – | ﹤0.01% | 1625 |
|
|
2023
Q3 | $557K | Hold |
262,662
| – | – | ﹤0.01% | 1561 |
|
|
2023
Q2 | $843K | Buy |
262,662
+37,499
| +17% | +$107K | 0.01% | 1364 |
|
|
2023
Q1 | $489K | Buy |
225,163
+50,422
| +29% | +$143K | ﹤0.01% | 1659 |
|
|
2022
Q4 | $423K | Sell |
174,741
-16,874
| -9% | -$37.8K | ﹤0.01% | 1745 |
|
|
2022
Q3 | $448K | Buy |
191,615
+54,876
| +40% | +$123K | ﹤0.01% | 1720 |
|
|
2022
Q2 | $212K | Sell |
136,739
-7,109
| -5% | -$10K | ﹤0.01% | 2279 |
|
|
2022
Q1 | $196K | Buy |
143,848
+28,689
| +25% | +$32K | ﹤0.01% | 2364 |
|
|
2021
Q4 | $140K | Buy |
115,159
+52,384
| +83% | +$75K | ﹤0.01% | 2273 |
|
|
2021
Q3 | $86K | Sell |
62,775
-57,828
| -48% | -$77.2K | ﹤0.01% | 2492 |
|
|
2021
Q2 | $170K | Buy |
120,603
+67,836
| +129% | +$98.7K | ﹤0.01% | 2254 |
|
|
2021
Q1 | $83.4K | Sell |
52,767
-75,063
| -59% | -$134K | ﹤0.01% | 2259 |
|
|
2020
Q4 | $203K | Sell |
127,830
-2,375
| -2% | -$4.33K | ﹤0.01% | 1975 |
|
|
2020
Q3 | $227K | Buy |
130,205
+37,387
| +40% | +$69.2K | ﹤0.01% | 1795 |
|
|
2020
Q2 | $202K | Hold |
92,818
| – | – | ﹤0.01% | 1897 |
|
|
2020
Q1 | $110K | Buy |
92,818
+69,480
| +298% | +$85.1K | ﹤0.01% | 2015 |
|
|
2019
Q4 | $31.7K | Sell |
23,338
-68,928
| -75% | -$99.6K | ﹤0.01% | 2289 |
|
|
2019
Q3 | $123K | Buy |
92,266
+2,024
| +2% | +$2.71K | ﹤0.01% | 2215 |
|
|
2019
Q2 | $127K | Hold |
90,242
| – | – | ﹤0.01% | 2272 |
|
|
2019
Q1 | $150K | Buy |
+90,242
| New | +$123K | ﹤0.01% | 2142 |
|
|
2018
Q4 | – | Sell |
-77,629
| Closed | -$137K | – | 2580 |
|
|
2018
Q3 | $137K | Sell |
77,629
-444
| -0.6% | -$1.94K | ﹤0.01% | 2294 |
|
|
2018
Q2 | $268K | Buy |
78,073
+32,772
| +72% | +$125K | ﹤0.01% | 1770 |
|
|
2018
Q1 | $193K | Sell |
45,301
-30,287
| -40% | -$81.8K | ﹤0.01% | 1911 |
|
|
2017
Q4 | $136K | Buy |
+75,588
| New | +$153K | ﹤0.01% | 2119 |
|
Other funds holding GERN
RCM
SCM
DTC
VCM
EP
MetLife Investment Management's GERN Position: Q1 2026 in Review
MetLife Investment Management reduced its Geron (GERN) stake by 16% in Q1 2026, selling an estimated $70.5K and leaving 250,662 shares worth $373K. The position accounts for ﹤0.01% of the portfolio, ranked #1895.
MetLife Investment Management first reported a position in GERN in Q4 2017 and has held it in 33 quarters since. The position peaked at $1.47M in Q3 2024. 256 funds tracked by Wall St. Rank hold GERN as of Q1 2026.
- MetLife Investment Management held 250,662 shares of Geron worth $373K as of Q1 2026.
- MetLife Investment Management sold 46,400 Geron shares in Q1 2026, an estimated $70.5K.
- Geron made up ﹤0.01% of MetLife Investment Management's portfolio in Q1 2026, its #1895 holding.
- MetLife Investment Management first reported a position in Geron in Q4 2017 and has held it in 33 quarters since.
- MetLife Investment Management's Geron position peaked at $1.47M in Q3 2024.
- 256 funds tracked by Wall St. Rank held Geron as of Q1 2026.
Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.